Lausanne, June 12th, 2019

Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.

Saphetor’s VarSome Clinical, a clinically-certified cloud-based platform empowering fast and accurate variant discovery, annotation, and interpretation of NGS data is now bundled with a number of Swift’s NGS-based clinical research targeted gene panels. The validated bundled solution enables biologists, geneticists, and medical doctors to process and interpret sequencing data more rapidly and precisely, using VarSome Clinical’s intuitive and feature-rich interface.

Nathan Wood, CEO of Swift Biosciences Inc., said: ‘This new partnership helps us to deliver high-quality, state-of-the-art bioinformatics services to our customers, and supports us in our mission to establish genomics as a central element of medicine of today and tomorrow.’

Andreas Massouras, CEO and Founder of Saphetor SA, commented: ‘We are very pleased to partner with Swift Biosciences and combine our offerings for the benefit of Swift’s rapidly growing number of customers.’

About Swift Biosciences Inc.

Swift Biosciences is the NGS Library Prep company. Based in Ann Arbor, Michigan, the company develops novel library preparation solutions for emerging applications based on next-